Testing Two New Drugs Together for Advanced Head and Neck Cancer

Plain-English translation of NCT07088211 on ClinicalTrials.gov ↗ · Source last updated June 2026 · Translation generated June 2026 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

What is this trial?

This trial is testing a combination of two medications——to treat head and neck squamous cell carcinoma that has returned or spread to other parts of the body. The study compares this new approach to what doctors currently know works best. Researchers believe this combination may help more patients and cause fewer side effects than the current standard treatment.

Many people with head and neck cancer experience the cancer coming back or spreading even after initial treatment, and current options don't work well enough—many patients only survive 6 to 9 months without treatment. This trial exists because the current standard medication requires weekly infusions and causes uncomfortable side effects like skin problems, so doctors are looking for better options that are easier to tolerate.

Do you qualify?

You likely qualify if…

you are between 18 and 75 years old
you have been diagnosed with head and neck squamous cell carcinoma that has returned or spread and cannot be treated with surgery or radiation
you have not received chemotherapy for your recurrent or metastatic disease (though you may have received it as part of earlier treatment, as long as more than 6 months have passed)
your cancer cells show specific markers called PD-L1 (CPS ≥ 1) and trop2 when tested
you are in good enough health to tolerate treatment, with normal blood counts, liver function, kidney function, and heart function

You likely don't qualify if…

your cancer progressed within 6 months of finishing chemotherapy for locally advanced head and neck cancer
you have a history of nasopharyngeal cancer (cancer in the upper throat behind the nose)
you have cancer that has spread to your brain or central nervous system
you have had a heart attack within the past year or unstable heart disease
you are pregnant or nursing, or unwilling to use effective birth control during and for 12 months after treatment

What participation looks like

You would receive the two medications as part of the trial's treatment plan. Based on the study design, you would likely visit the hospital or clinic regularly for infusions and to have your blood checked and your cancer monitored with scans. The trial involves 39 patients total, and doctors will carefully watch how well the treatment works and what side effects you experience. Your tumor tissue will also be tested before treatment begins to confirm it has the right markers.

AI-generated summary from trial data · Jun 24, 2026 · Not medical advice

Trial locations(1 site)

China

the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality